Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Sutter

Showing results (131-140 of 179) with videos related to

Pageof 18
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2002
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing miceVincenzo Bronte, Paolo Serafini, Carmela De Santo, et al.
Cell Reports. Medicine|July 20, 2022
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccineLeonie M Weskamm, Anahita Fathi, Matthijs P Raadsen, et al.
Frontiers in Immunology|May 8, 2023
A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infectionMareike Kubinski, Jana Beicht, Isabel Zdora, et al.
Pathogens (Basel, Switzerland)|July 29, 2023
Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in MiceMartin C Langenmayer, Anna-Theresa Luelf-Averhoff, Lisa Marr, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 12, 2024
A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responsesJuan J Rojas, Lien Van Hoecke, Miquel Conesa, et al.
Annals of the Rheumatic Diseases|July 6, 2021
B cell depletion impairs vaccination-induced CD8<sup>+</sup> T cell responses in a type I interferon-dependent mannerTheresa Graalmann, Katharina Borst, Himanshu Manchanda, et al.
Vaccines|April 23, 2022
Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus NucleoproteinAlexandra Kupke, Asisa Volz, Erik Dietzel, et al.
Vaccine|March 5, 2016
Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigensAsisa Volz, Stephanie Lim, Martina Kaserer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Differences between T cell epitopes recognized after immunization and after infectionThorsten U Vogel, Helen Horton, Deborah H Fuller, et al.
Nature Immunology|November 16, 2005
A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNAKen J Ishii, Cevayir Coban, Hiroki Kato, et al.
Pageof 18

Showing results (131-140 of 179) with videos related to

Sort By:
Pageof 18
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2002
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing miceVincenzo Bronte, Paolo Serafini, Carmela De Santo, et al.
Cell Reports. Medicine|July 20, 2022
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccineLeonie M Weskamm, Anahita Fathi, Matthijs P Raadsen, et al.
Frontiers in Immunology|May 8, 2023
A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infectionMareike Kubinski, Jana Beicht, Isabel Zdora, et al.
Pathogens (Basel, Switzerland)|July 29, 2023
Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in MiceMartin C Langenmayer, Anna-Theresa Luelf-Averhoff, Lisa Marr, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 12, 2024
A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responsesJuan J Rojas, Lien Van Hoecke, Miquel Conesa, et al.
Annals of the Rheumatic Diseases|July 6, 2021
B cell depletion impairs vaccination-induced CD8<sup>+</sup> T cell responses in a type I interferon-dependent mannerTheresa Graalmann, Katharina Borst, Himanshu Manchanda, et al.
Vaccines|April 23, 2022
Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus NucleoproteinAlexandra Kupke, Asisa Volz, Erik Dietzel, et al.
Vaccine|March 5, 2016
Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigensAsisa Volz, Stephanie Lim, Martina Kaserer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Differences between T cell epitopes recognized after immunization and after infectionThorsten U Vogel, Helen Horton, Deborah H Fuller, et al.
Nature Immunology|November 16, 2005
A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNAKen J Ishii, Cevayir Coban, Hiroki Kato, et al.
Pageof 18